PRIMARY STUDY

Evidence for the use of cannabinoids in Parkinson's disease

Key Findings:  The reviewers note that while there is an increasing understanding of how engaging the ECS might produce therapeutic effects in patients with PD, based on the available literature at the time of their review only one of four conducted randomized placebo-controlled trials produced therapeutic effect on motor symptoms with a of levodopa-induced dyskinesia.

Type of Study:  Meta-analysis

Study Result:  Positive


Cannabinoids Studied:  Cannabinoid (unspecified)

Phytocannabinoid Source:  Not Applicable

Form of Administration:  Not Applicable


Study Location(s):  Germany

Year of Pub:  2019


Link to study